We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Silicone Breast Implant Device Significantly Reduces Contamination

By HospiMedica International staff writers
Posted on 15 Feb 2012
A novel device used in the delivery of silicone gel implants during breast enlargement procedures helps reduce breast skin-flora contamination by more than 50% over the standard technique. More...


The Keller Funnel is designed to facilitate and improve the delivery of silicone gel implants by allowing surgeons to use a minimal or no-touch technique during breast augmentation procedures. Instead of the finger pushing and thrusting motion required by a surgeon to successfully place an implant in the traditional method, the tip of the Keller Funnel is inserted into the incision, and the doctor gently propels the implant into the newly created breast pocket, while protecting the implant from contacting the skin, which could lead to reduced patient infection rates and reduced capsular contracture.

In a cadaver study conducted at Emory University (Atlanta, GA, USA), the researchers concluded that the Keller Funnel significantly reduced the amount of skin contact and potential contamination during breast implantation. The study was published in the February 2012 issue of the Aesthetic Surgery Journal. Other benefits to women include significantly reducing force on the implant shell, which can prevent a future rupture, shortening incision lengths, and minimizing postoperative bruising and swelling. The Keller Funnel is a product of Keller Medical (Stuart, FL, USA), and has been approved by the US Food and Drug Administration (FDA).

“Based on a recent survey among 300 surgeons with varying degrees of experience using the Funnel, we know that the device improves the delivery of silicone implants by making the procedure easier, and that doctors believe it reduces the introduction of contaminants thought to be the major cause of capsular contracture,” said Howard Preissman, CEO of Keller Medical.

Capsular contracture is a painful condition where breasts feel hardened and become distorted. It occurs in 10%-15% of all women who undergo breast augmentation procedures, and is the most common complication requiring reoperation. Multiple factors likely cause contracture, with infection being one of the most significant contributors.

Related Links:

Emory University
Keller Medical



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.